PRLog - May 1, 2015 - NEW YORK -- Growing up in Sabinov, Slovakia, Martin and Damian Trisc shared a lot. They shared books, toys, and clothes because that’s what brothers do. Sadly, today, siblings Martin, 27, and Damian, 22, share the same genetic disorder, Wilson’s disease.
Wilson's disease is a rare, inherited disorder that causes too much copper to accumulate in the liver, brain, and other vital organs. Symptoms typically begin between the ages of 12 and 23. Copper plays a key role in the development of healthy nerves, bones, collagen, and the skin pigment melanin. Normally, copper is absorbed from your food, and any excess is excreted through bile — a substance produced in your liver. But in people with Wilson's disease, copper isn't eliminated properly and instead accumulates, possibly to a life-threatening level. When diagnosed early, Wilson's disease is treatable, and many people with the disorder live normal lives. Unfortunately, since their diagnoses in late 2013 and early 2014, that is not the case with the Trisc brothers. Both continued to experience declining health and required around the clock care.
Martin was once an athlete who played soccer, was an avid bicyclist, and a roller blader. Due to his illness, he could barely tie his own shoes and was not able to eat or shave by himself.
Damian dreamt of being a dentist and put all of his energy in to his studies. In high school, he was the gold medalist in both the math and physics Olympics, but he had to put his college studies on hold due to his illness.
Wilson’s disease put a tremendous amount of stress on the entire family, which has been seeking ways to stop the progression of Martin’s and Damian’s disease. Fortunately, through the Consul General of Slovakia in New York, Hon. Jana Trnovcova, the family learned about a young girl in China who suffered the same fate, but after several treatments with stem cell therapies, she experienced incredible improvements. She was treated by Dongcheng Wu, M.D., Ph.D., a stem cell scientist at Blue Horizon Stem Cells in Wuhan, China.
After learning more about the therapy, the Trisc family traveled to China and received treatment at Blue Horizon Stem Cells' facility in Wuhan in February 2015. Upon their return to Slovakia, both of them, as well as their family members and friends, noticed dramatic improvement in their conditions.
Mrs. Triscova, their mother, said, “Damian could hardly speak and it was extremely difficult to communicate with him, his driver’s license was revoked and he had to put his college studies on hold. After the treatment, he is a new person – he even got his driver’s license back. Martin was not able to eat or shave by himself before, and now all these tasks are possible for him to perform daily. His overall energy levels are up, and he has found a joy in life again. He is hoping to get back to work soon."
"The prognosis in this case is promising. We hope that the Trisc brothers will continue to experience improvements," said Brian Mehling, M.D., CMO of Blue Horizon Stem Cells, a division of Blue Horizon International.
As founder, Dr. Mehling has overseen a newly opened treatment and research facility in Malacky, Slovakia. He has also managed the premiere of a clinic in China, where more than 3,000 stem cell treatment procedures on over 700 patients have been successfully performed. By strategically placing the new clinic in Slovakia the most innovative treatments within the stem cell field are now available for the global market.
Blue Horizon International is a healthcare consulting company with a unique mission that combines treatment, research and philanthropic efforts. Across the globe quality care and services for medical treatments are provided along with resources needed to assist children and adults who are medically underserved. For more information please visit Blue Horizon International at www.bluehorizonhospital.com.
Blue Horizon Stem Cells is a division of Blue Horizon International that provides stem cell therapy and research to achieve health benefits. Uniquely positioned to take advantage of its clinical research, Blue Horizon Stem Cells has safely and efficiently performed over 2250 procedures, documenting each procedure while tracking the progress of patients throughout their treatment cycle. Blue Horizon International’s stem cell therapy program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science in Wuhan, China and Malacky Hospital in Slovakia. For more information visit www.bluehorizonstemcells.com.
Read Full Story - Brothers from Slovakia Travel to China for Blue Horizon Stem Cell Therapy | More news from this source
Press release distribution by PRLog
Brothers from Slovakia Travel to China for Blue Horizon Stem Cell Therapy
May 01, 2015 at 09:42 AM EDT
